Jeffrey Karp

Contributing Author

2024 - Current

Co-Founder

2022

Author of LIT - Life Ignition Tools (Harper Collins - William Morrow Imprint)

2019

✨Please consider pre-ordering at your favorite retailer: http://bit.ly/3OUGWCO 🙏🏻 Life Ignition Tools are a set of holistic tools for living that emerged out of necessity from my own life. As a child struggling with undiagnosed ADHD and learning differences, I learned how to essentially take control of my brain’s neuroplasticity (neuroplasticity reflects our intrinsic link to nature - it's how our brain adapt and evolve in response to our environment and our thoughts, emotions, and actions) – it was a lifesaver! It gave me the ability to laser focus, enter the flow state on demand, improve memory, emotionally regulate, and more. Named LIT, these tools, inspired by nature and backed by science, empower anyone to lead a life rich in creativity, connection, and purpose. LIT got me through spectacular setbacks along the way (including being rejected from medical school, freezing during a TED talk, struggling to connect meaningfully with others, and countless other challenges) and to where I am today. And the thing is - anyone can do this and start living a life full of creativity, and connection and purpose. Additionally, "LIT" features insights from 40 interviewees, including Nobel laureates, Olympic medalists, social justice leaders, an indigenous leader, celebrated artists, and various scientists and inventors. They share their experiences disengaging from life on autopilot by activating the brain's inherent power to undergo transformative change.

Co-Founder

2019

Professor of Anesthesia

2007

Associate Professor

2012 - 2018

Co-Director of Regenerative Therapeutics

2010 - 2013

Assistant Professor

2009 - 2012

Instructor of Medicine

2007 - 2009

Co-Founder

2015

Editorial Advisory Board Member

2015

Honored to serve on the 2015,2016 and 2017 TEDMED Editorial Advisory Board for curating the stage program’s themes, topics, speakers and performers.

Co-Founder, Scientific Advisory Board Member, and Board Observer

2016

Associate Member

2015

Co-Founder, Member of the Regenerative Medicine Advisory Board

2014

Frequency Therapeutics, is a biotechnology company at the forefront of translating ground breaking discoveries in the area of cell programming, an approach recognized with the 2012 Nobel Prize, to patients. Frequency has solved a key bottleneck in bringing stem cell programming to patients - namely by harnessing rapidly translatable small molecule combinations that selectively target stem cells in the body. The company is advancing a robust pipeline of small molecule combinations with novel mechanisms of action for hearing loss, gut diseases (including Crohn's disease and ulcerative colitis), diabetes, and ophthalmological diseases.